tiprankstipranks
Trending News
More News >
Q32 Bio (QTTB)
NASDAQ:QTTB
US Market

Q32 Bio (QTTB) Financial Statements

Compare
904 Followers

Q32 Bio Financial Overview

Q32 Bio's market cap is currently $65.58M. The company's EPS TTM is $4.58; its P/E ratio is -0.82; Q32 Bio is scheduled to report earnings on March 10, 2026, and the estimated EPS forecast is $-0.68. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ -6.65M$ 6.65M$ 33.97M
Gross Profit$ 0.00$ -487.00K$ -6.65M$ 6.65M$ 24.43M
Operating Income$ 16.90M$ -66.10M$ -48.26M$ -39.23M$ -95.95M
EBITDA$ 16.90M$ -45.30M$ -47.76M$ -38.85M$ -86.22M
Net Income$ 29.82M$ -47.73M$ -53.74M$ -42.81M$ -95.76M
Balance Sheet
Cash & Short-Term Investments$ 48.30M$ 77.97M$ 25.62M$ 43.89M$ 155.87M
Total Assets$ 61.78M$ 92.33M$ 47.06M$ 61.77M$ 211.72M
Total Debt$ 11.18M$ 18.90M$ 50.84M$ 44.73M$ 23.93M
Net Debt$ -37.12M$ -59.06M$ 25.22M$ 838.00K$ -84.45M
Total Liabilities$ 19.76M$ 86.66M$ 229.98M$ 192.49M$ 42.07M
Stockholders' Equity$ 42.01M$ 5.67M$ -182.92M$ 177.98M$ 169.65M
Cash Flow
Free Cash Flow$ -24.18M$ -67.79M$ -18.68M$ -13.44M$ -112.15M
Operating Cash Flow$ -24.19M$ -67.72M$ -18.68M$ -10.96M$ -109.75M
Investing Cash Flow$ 2.00K$ 19.93M$ -5.00K$ -2.47M$ -50.79M
Financing Cash Flow$ -3.13M$ 95.14M$ 406.00K$ 30.07M$ 52.17M
Currency in USD

Q32 Bio Earnings and Revenue History

Q32 Bio Debt to Assets

Q32 Bio Cash Flow

Q32 Bio Forecast EPS vs Actual EPS